| Drug Name: | Chlorambucil (305-03-3) |
|---|---|
| PubChem ID: | 2708 |
| SMILES: | C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl |
| InchiKey: | JCKYGMPEJWAADB-UHFFFAOYSA-N |
| Therapeutic Category: | Alkylating Agents, Antineoplastic Agents, Noxae |
| Molecular Weight (dalton) | : | 304.217 |
| LogP | : | 3.3779 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 40.54 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Prednisone (53-03-2) | Generalised Tonic-Clonic Seizure | Additives | The seizures in this patient may have been due to the additive effects of both drugs | Chlorambucil/prednisone-induced seizures in a patient with non-Hodgkin's lymphoma |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category